5 Costliest Drugs for Medicare

The Agency for Healthcare Research and Quality releases statistical briefs with insights on healthcare cost and quality. The following is a list of the top five most costly prescription drugs by total expense prescribed to Medicare beneficiaries in 2010 as reported in AHRQ’s Statistical Brief #411. Combined, these drugs accounted for 68.23 percent of Medicare prescription drug spending, totaling $63.4 billion.

Advertisement

1. Metabolic agents ($22.5 billion). These drugs accounted for nearly a quarter of all Medicare beneficiary prescription drug spending. On average, metabolic agents cost $98 dollars per prescription. Nearly 60 percent of Medicare beneficiaries had a prescription for a metabolic agent.

2. Cardiovascular agents ($14.6 billion). These drugs accounted for 15.7 percent of all Medicare beneficiary prescription drug spending. On average, cardiovascular agents cost $40 per prescription. About 71 percent of beneficiaries held a prescription for cardiovascular medication.

3. Central nervous system agents ($11.1 billion). These drugs accounted for 12 percent of Medicare beneficiary prescription drug spending. On average, a CNS drug prescription cost $80 dollars. Almost 43 percent of Medicare beneficiaries were prescribed CNS agents.

4. Respiratory agents ($7.8 billion). These drugs accounted for 8.4 percent of Medicare beneficiary prescription drug spending. An average respiratory agent prescription cost $139 dollars. Nearly 18 percent of Medicare beneficiaries had a prescription for a respiratory drug.

5. Gastrointestinal agents ($7.5 billion). These dugs accounted for 8.1 percent of Medicare beneficiary prescription drug spending. An average prescription for a gastrointestinal drug cost $111 dollars. Approximately 26 percent of beneficiaries had a prescription for a gastrointestinal agent.

More Articles on Medicare:

3 Strategies to Contain Acute-Care Costs

CMS: Chronic Care Management, SGR Main Issues for Physician Pay in 2014

Observation Status Patients Cost More Than Those Admitted, Study Finds

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

When nurses help build the AI, adoption follows: Lessons from 3 health systems

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Amy McCarthy, DNP, RNC-MNN, NE-BC, CENP, Hippocratic AIBeth Reimschissel, PhD, RN, CNL, Memorial HermannAllison Schlinkert, MSN, RN, NPD-BC, Cincinnati Children'sScott Estep, MBOE, BSN, RN, CSSBB, OhioHealth System

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.